All In Biotech

Free tool

FAERS Monitor: Trokendi Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 201635 or its brand name (Trokendi Xr, Topiramate). Reports on generic versions are filed under their own applications.

Reports

52,165

Serious

39,159

75% of reports

Hospitalization

14,539

Death reported

5,671

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective7,246
  • off label use5,862
  • headache3,836
  • nausea3,417
  • fatigue3,277
  • migraine2,702
  • product use in unapproved indication2,649
  • pain2,622
  • dizziness2,499
  • seizure2,336
  • diarrhoea2,259
  • condition aggravated2,232
  • vomiting2,209
  • drug intolerance2,149
  • depression2,007

Reports by year received

View as table
YearReports
2004139
2005254
2006207
2007196
2008383
2009775
2010941
20111,213
20121,395
20131,215
20141,569
20152,488
20163,070
20172,875
20183,779
20194,340
20203,915
20213,856
20223,667
20233,947
20244,606
20254,491
20262,839

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,001,994 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
migraineSignal2,70211.711.325,840
drug intoleranceSignal2,1499.28.815,317
seizureSignal2,3368.38.014,773
product use in unapproved indicationSignal2,6494.34.26,827
depressionSignal2,0073.63.43,735
condition aggravatedSignal2,2323.02.92,945
off label useSignal5,8622.72.66,558
headacheSignal3,8362.52.43,456
drug ineffectiveSignal7,2462.22.25,175
dizzinessSignal2,4992.01.91,321
vomiting2,2091.91.8956
nausea3,4171.71.71,121
pain2,6221.71.7817
fatigue3,2771.71.6976
diarrhoea2,2591.41.4279

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.